REUTERS/Carlo Allegri With more than 40 million doses of coronavirus vaccines available, US health authorities said they’re confident there will be enough for both qualified older Americans seeking booster shots…
Billions more in profits are at stake for some vaccine makers as the US moves toward dispensing Covid-19 booster shots to shore up Americans’ protection against the virus. How much…
CHICAGO: New data from Moderna Inc’s large Covid-19 vaccine trial shows that the protection it offers declines over time, supporting the case for booster doses, the company said in a…
Pfizer recently announced that Jade Dare (B7451050), a 26-week, randomised, double-blind, double-dummy, active-controlled, multi-center phase-III study, met its co-primary and key secondary efficacy endpoints. The study showed that abrocitinib was…
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by…
